The safety of patients is a priority. The Corlife is very interested in feedback from treating physicians after implantation. This is the best way we can identify potential for improvement and reduce risks in good time.

Implant-ID and SEC

Each cell-free allograft is accompanied by an implant identification card. The card shows the serial number of the cell-free allograft (Single European Code, SEC). Use the SEC to learn more about cell-free allograft here . Please present the implant ID card to the patient. The ID card should be kept in a safe place and be available in case of need.


Corlife is funding an independent study on the long-term safety and efficacy of cell-free allografts. This study is coordinated by the Hannover Medical School. Participation is voluntary for both patients and participating physicians.

Please connect with, if you want to join SALAMANDRA.

Reporting suspected adverse reactions

Adverse reactions are harmful and unintended reactions to the cell-free allograft. Reporting adverse reactions helps to provide more information on the safety of cell-free allografts:

  • Please inform your patients that they should contact their doctor or healthcare professional if they notice any adverse reaction.
  • Patients should report any suspected adverse reaction to the competent authority . This also applies to adverse reactions that are not mentioned in the package leaflet. Medical professionals please report here.

Related Topics